Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 225 publications
Evaluating Hip Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis.
Journal: The Journal of rheumatology
Published: April 15, 2026
Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2026
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.
Journal: Journal for immunotherapy of cancer
Published: February 10, 2026
Primary resistance to ICI-based regimens is associated with early longitudinal changes in the fecal microbiome and loss of microbial stability.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Evaluating Hip Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis.
Journal: The Journal of rheumatology
Published: November 18, 2025
Macrophage CCL18 Promotes Lung Inflammation in Checkpoint Inhibitor Pneumonitis.
Journal: American journal of respiratory cell and molecular biology
Published: October 10, 2025
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer.
Journal: Cancer research communications
Published: September 15, 2025
Novel Predictive Spatial Biomarker in Non-Small Cell Lung Carcinoma: The Diversity of Niches Unlocking Treatment Sensitivity (DONUTS).
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2025
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses.
Journal: Nature medicine
Published: July 18, 2025
Macrophage CCL18 promotes lung inflammation in checkpoint inhibitor pneumonitis.
Journal: American journal of respiratory cell and molecular biology
Published: July 08, 2025
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.
Journal: The New England journal of medicine
Published: June 02, 2025
Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy.
Journal: Cancer research communications
Published: May 05, 2025
Last Updated: 09/26/2026